Gastrointestinal Side Effects Gastrointestinal (GI) side effects are the most common side effects reported by patients taking semaglutide
Every participant had obesity (BMI of at least 30 kg/m) together with moderate-to-severe alcohol use disorder and was seeking professional treatment
Genitourinary Common (1% to 10%): Urinary tract infection, urolithiasis Postmarketing reports : Urolithiasis Hepatic Common (1% to 10%): Cholelithiasis, cholecystitis Uncommon (0.1% to 1%): Increased bilirubin Postmarketing reports : Cholecystitis, cholelithiasis requiring cholecystectomy Hypersensitivity Uncommon (0.1% to 1%): Hypersensitivity Rare (0.01% to 0.1%): Anaphylactic reaction Frequency not reported : Allergic reactions Postmarketing reports : Hypersensitivity, anaphylaxis Hypersensitivity included related adverse events such as rash and urticaria
Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis
Experience the future of beauty with innovative treatments that prioritize long-term skin health, radiance, and overall well-being.
[8] [9] The MHRA continues to monitor the safety profile of these medications as their use expands
